Tag: Menopause / Postmenopause
Menopausal Hormone Therapy Use Beyond 65 Years Beneficial
Hormone therapy use linked to risk reductions in mortality
Endocrine, Vascular Processes Contribute to Cognitive Decline in Women
Earlier menopause and higher vascular risk synergistically associated with lower cognitive scores at follow-up
ACC: Coronary Artery Calcium Progression May Accelerate After Menopause
Authors say sharp increase in cardiovascular risk warrants more regular screening
Earlier Menopause Tied to Poorer Self-Perceived Work Ability
Additionally, it predicts lower recorded work participation and higher disability pension rate in subsequent years
Menopausal Hormone Therapy May Improve Depression Symptoms
Authors say more studies are needed to understand ideal timing window for treatment initiation
Female Reproductive Factors Linked to Risk for COPD
Age at menarche, number of children, number of miscarriages and stillbirths, age at natural menopause linked to COPD
Common Tools Suboptimal for ID’ing Fracture Risk in Younger Postmenopausal Women
Findings seen for the Fracture Risk Assessment Tool and the Osteoporosis Self-Assessment Tool
Fracture Risk Up With Prediabetes Before Menopause Transition
Increased risk of fracture after adjustment for confounding variables, including bone mineral density
Oral Contraceptives May Protect Against Rheumatoid Arthritis
In contrast, use of menopausal hormone therapy may increase the risk for late-onset rheumatoid arthritis
Moderate, Heavy Use of Chemical Hair Relaxer Linked to Uterine Cancer
Among postmenopausal women, moderate and heavy use associated with increased risk versus never/light use
